Research News and Research

RSS

Researchers assess the damage caused by microbubbles in brain injuries

Say there's a bomb attack on a military base. A few of the soldiers suffer concussions and other brain injuries. Could some of the injuries be caused by tiny bubbles that form and collapse within the skull during head trauma?

23 Jul 2020

NIH leaders create a framework to scale up testing technologies for COVID-19

In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease.

23 Jul 2020

C-Path gets positive response from FDA for drug-induced skeletal muscle injury safety biomarkers

Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.

23 Jul 2020

COVID-19: Older adults fared better emotionally than younger and middle-aged people

Adults aged 60 and up have fared better emotionally compared to younger adults (18-39) and middle-aged adults (40-59) amid the COVID-19 pandemic, according to new UBC research published recently in the Journal of Gerontology: Psychological Sciences.

23 Jul 2020

Study identifies common characteristics of pediatric vestibular schwannomas

Vestibular schwannomas, more commonly known as acoustic neuromas, are benign brain tumors that develop on the balance (vestibular) and hearing or auditory nerves leading from the inner ear to the brain.

23 Jul 2020

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease.

23 Jul 2020

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 -- the virus that causes the disease -- drop sharply over the first three months after infection, decreasing by roughly half every 73 days.

23 Jul 2020

New biomolecules can benefit agricultural and pharmaceutical sectors

These molecules of plant origin may be of use to the agricultural and pharmaceutical sectors. Researchers from the Biochemistry and Biotechnology Research Group at the Universitat Jaume Ihave identified and obtained biomolecules of plant origin, which have been tested against plant pathogens and pathogens of clinical interest, with the aim of obtaining high-quality commercial products that can be applied in the agricultural and pharmaceutical sectors.

23 Jul 2020

Amyloid plaques may act as trigger for Alzheimer's disease

The brains of people living with Alzheimer's are riddled with plaques: protein aggregates consisting mainly of amyloid-beta.

23 Jul 2020

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Ashion Analytics LLC today announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.

23 Jul 2020

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

For-profit status is associated with the extent of an outbreak of coronavirus disease 2019 (COVID-19) in long-term care (LTC) homes and the number of resident deaths from COVID-19, but not the likelihood of an outbreak, which was related to the infection rate in the surrounding local public health unit and the total number of beds in the home, found new research published in CMAJ (Canadian Medical Association Journal).

23 Jul 2020

Findings could help design vaccines against coronavirus

Scientists investigating the evolution of the virus that causes Covid19 say that its mutation seems to be directed by human proteins that degrade it, but natural selection of the virus enables it to bounce back. The findings could help in the design of vaccines against the virus.

23 Jul 2020

Study finds viable drug target for triple negative breast cancer

One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), UTSW researchers report in a new study.

23 Jul 2020

Science identifies rare, healthy sugar in native stingless bee honey

Science has validated Indigenous wisdom by identifying a rare, healthy sugar in native stingless bee honey that is not found in any other food.

23 Jul 2020

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit.

23 Jul 2020

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

New approach tracks tumors in real time, could improve outcomes for cancer patients

A team of University of Alberta researchers has developed a faster way of tracking the movement of tumours in the body during radiation therapy, which could significantly improve outcomes for cancer patients.

23 Jul 2020

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Report highlights the need to improve quality of care for high-risk veterans

Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report.

22 Jul 2020

Calcium channel subunits play a crucial role in neurological disorders

The ability of the human brain to process and store information is determined to a large extent by the connectivity between nerve cells.

22 Jul 2020

Research News and Research

Researchers assess the damage caused by microbubbles in brain injuries

NIH leaders create a framework to scale up testing technologies for COVID-19

C-Path gets positive response from FDA for drug-induced skeletal muscle injury safety biomarkers

COVID-19: Older adults fared better emotionally than younger and middle-aged people

Study identifies common characteristics of pediatric vestibular schwannomas

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Study shows antibodies drop sharply in first three months after mild COVID-19 cases

New biomolecules can benefit agricultural and pharmaceutical sectors

Amyloid plaques may act as trigger for Alzheimer's disease

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths

Findings could help design vaccines against coronavirus

Study finds viable drug target for triple negative breast cancer

Science identifies rare, healthy sugar in native stingless bee honey

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

New approach tracks tumors in real time, could improve outcomes for cancer patients

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Report highlights the need to improve quality of care for high-risk veterans

Calcium channel subunits play a crucial role in neurological disorders

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery